(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -1.63% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Pfizer's revenue in 2025 is $63,833,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2025 to be $360,463,640,164,677, with the lowest PFE revenue forecast at $353,407,166,985,915, and the highest PFE revenue forecast at $363,932,087,505,000. On average, 6 Wall Street analysts forecast PFE's revenue for 2026 to be $356,591,638,135,415, with the lowest PFE revenue forecast at $345,748,332,473,880, and the highest PFE revenue forecast at $362,543,875,067,168.
In 2027, PFE is forecast to generate $343,249,771,822,251 in revenue, with the lowest revenue forecast at $331,551,797,152,905 and the highest revenue forecast at $350,375,694,000,371.